Arsenic exposure affects plasma Insulin-Like Growth Factor 1 (IGF-1) in children in rural Bangladesh

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Ahmed, Sultan ^a,b   Rekha, Rokeya Sultana ^a   Ahsan, Khalid Bin ^a   Doi, Mariko ^c   Grandér, Margaretha ^b   Roy, Anjan Kumar ^a   Ekström, Eva Charlotte ^d   Wagatsuma, Yukiko ^c   Vahter, Marie ^b   Raqib, Rubhana ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; ARSENIC; CALCIUM; METHANEARSONIC ACID; PARATHYROID HORMONE; PHOSPHATE; SOMATOMEDIN C; VITAMIN D;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BANGLADESH; BODY HEIGHT; BODY WEIGHT; CALCIUM BLOOD LEVEL; CHILD; CHILD GROWTH; DIET SUPPLEMENTATION; FEMALE; GROWTH RETARDATION; HORMONE BLOOD LEVEL; HUMAN; MALE; NEWBORN; PARITY; PHOSPHATE BLOOD LEVEL; POPULATION EXPOSURE; PRENATAL EXPOSURE; PRESCHOOL CHILD; RURAL POPULATION; SEX DIFFERENCE; SOCIOECONOMICS; STUNTING; UMBILICAL CORD BLOOD; UNDERWEIGHT; URINE LEVEL; VITAMIN BLOOD LEVEL;

ADOLESCENT; ARSENIC; BANGLADESH; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR I; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PUBLIC HEALTH SURVEILLANCE; RURAL POPULATION;

EID: 84896737591     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081530     Document Type: Article

References (44)

1. Ahmad SA, Sayed MH, Barua S, Khan MH, Faruquee MH et al. (2001) Arsenic in drinking water and pregnancy outcomes. Environ Health Perspect 109: 629-631. doi:10.1289/ehp.01109629. PubMed: 11445518. (Pubitemid 32998776)
2. Hopenhayn-Rich C, Browning SR, Hertz-Picciotto I, Ferreccio C, Peralta C et al. (2000) Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environ Health Perspect 108: 667-673. doi:10.1289/ehp.00108667. PubMed: 10903622. (Pubitemid 30657873)
3. Milton AH, Smith W, Rahman B, Hasan Z, Kulsum U et al. (2005) Chronic arsenic exposure and adverse pregnancy outcomes in Bangladesh. Epidemiology 16: 82-86. doi:10.1097/00001648-200509000-00205. PubMed: 15613949. (Pubitemid 40239281)
4. Rahman A, Vahter M, Ekström EC, Rahman M, Golam Mustafa AH et al. (2007) Association of arsenic exposure during pregnancy with fetal loss and infant death: a cohort study in Bangladesh. Am J Epidemiol 165: 1389-1396. doi:10.1093/aje/kwm025. PubMed: 17351293. (Pubitemid 47234306)
5. Yang CY, Chang CC, Tsai SS, Chuang HY, Ho CK et al. (2003) Arsenic in drinking water and adverse pregnancy outcome in an arseniasis-endemic area in northeastern Taiwan. Environ Res 91: 29-34. doi:10.1016/S0013-9351(02)00015-4. PubMed: 12550085.
6. Kippler M, Wagatsuma Y, Rahman A, Nermell B, Persson LA et al. (2012) Environmental exposure to arsenic and cadmium during pregnancy and fetal size: a longitudinal study in rural Bangladesh. Reprod Toxicol 34: 504-511. doi:10.1016/j.reprotox.2012.08.002. PubMed: 22985739.
7. Rahman A, Vahter M, Smith AH, Nermell B, Yunus M et al. (2009) Arsenic exposure during pregnancy and size at birth: a prospective cohort study in Bangladesh. Am J Epidemiol 169: 304-312. PubMed: 19037006.
8. Gardner RM, Kippler M, Tofail F, Bottai M, Hamadani J et al. (2013) Combined environmental exposures to metals and children's growth to five years: a prospective cohort study. American J Epidemiol (In press).
9. Lindgren A, Vahter M, Dencker L (1982) Autoradiographic studies on the distribution of arsenic in mice and hamsters administered 74Asarsenite or -arsenate. Acta Pharmacol Toxicol (Copenh) 51: 253-265. (Pubitemid 12053057)
10. Lindgren A, Danielsson BR, Dencker L, Vahter M (1984) Embryotoxicity of arsenite and arsenate: distribution in pregnant mice and monkeys and effects on embryonic cells in vitro. Acta Pharmacol Toxicol (Copenh) 54: 311-320. PubMed: 6730986. (Pubitemid 14134442)
11. Hill DS, Wlodarczyk BJ, Finnell RH (2008) Reproductive consequences of oral arsenate exposure during pregnancy in a mouse model. Birth Defects Res B Dev Reprod Toxicol 83: 40-47. doi:10.1002/bdrb.20142. PubMed: 18186108. (Pubitemid 351317792)
12. Willhite CC (1981) Arsenic-induced axial skeletal (dysraphic). Disorders - Exp Mol Pathol 34: 145-158. doi:10.1016/0014-4800(81)90071-X.
13. Lammon CA, Hood RD (2004) Effects of protein deficient diets on the developmental toxicity of inorganic arsenic in mice. Birth Defects Res B Dev Reprod Toxicol 71: 124-134. doi:10.1002/bdrb.20006. PubMed: 15282733. (Pubitemid 39031152)
14. Odstrcil Adel C, Carino SN, Ricci JC, Mandalunis PM (2010) Effect of arsenic in endochondral ossification of experimental animals. Exp Toxicol Pathol 62: 243-249. PubMed: 19447590.
15. Saha KK, Engström A, Hamadani JD, Tofail F, Rasmussen KM et al. (2012) Pre- and postnatal arsenic exposure and body size to 2 years of age: a cohort study in rural Bangladesh. Environ Health Perspect 120: 1208-1214. doi:10.1289/ehp.1003378. PubMed: 22504586.
16. Hopenhayn C, Ferreccio C, Browning SR, Huang B, Peralta C et al. (2003) Arsenic exposure from drinking water and birth weight. Epidemiology 14: 593-602. doi:10.1097/01.ede.0000072104.65240.69. PubMed: 14501275. (Pubitemid 40417041)
17. Casazza K, Higgins PB, Fernández JR, Goran MI, Gower BA (2008) Longitudinal analysis of the insulin-like growth factor system in African-American and European American children and adolescents. J Clin Endocrinol Metab 93: 4917-4923. doi:10.1210/jc.2008-0999. PubMed: 18782874.
18. Fall CH, Pandit AN, Law CM, Yajnik CS, Clark PM et al. (1995) Size at birth and plasma insulin-like growth factor-1 concentrations. Arch Dis Child 73: 287-293. doi:10.1136/adc.73.4.287. PubMed: 7492190.
19. Ibáñez L, Sebastiani G, Lopez-Bermejo A, Díaz M, Gómez-Roig MD et al. (2008) Gender specificity of body adiposity and circulating adiponectin, visfatin, insulin, and insulin growth factor-I at term birth: relation to prenatal growth. J Clin Endocrinol Metab 93: 2774-2778. doi:10.1210/jc.2008-0526. PubMed: 18460569. (Pubitemid 352008550)
20. Hyun SE, Lee BC, Suh BK, Chung SC, Ko CW et al. (2012) Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents. Clin Biochem 45: 16-21. doi:10.1016/j.clinbiochem.2011.10.003. PubMed: 22032863.
21. Yüksel B, Özbek MN, Mungan NO, Darendeliler F, Budan B et al. (2011) Serum IGF-1 and IGFBP-3 levels in healthy children between 0 and 6 years of age. J Clin Res Pediatr Endocrinol 3: 84-88. doi:10.4274/jcrpe.v3i2.17. PubMed: 21750637.
22. Scarth JP (2006) Modulation of the growth hormone-insulin-like growth factor (GH-IGF) axis by pharmaceutical, nutraceutical and environmental xenobiotics: an emerging role for xenobiotic-metabolizing enzymes and the transcription factors regulating their expression. A review. Xenobiotica 36: 119-218. doi:10.1080/00498250600621627. PubMed: 16702112.
23. Hong GM, Bain LJ (2012) Sodium arsenite represses the expression of myogenin in C2C12 mouse myoblast cells through histone modifications and altered expression of Ezh2, Glp, and Igf-1. Toxicol Appl Pharmacol 260: 250-259. doi:10.1016/j.taap.2012.03.002. PubMed: 22426358.
24. Puzik A, Rupp J, Tröger B, Göpel W, Herting E et al. (2012) Insulin-like growth factor-I regulates the neonatal immune response in infection and maturation by suppression of IFN-gamma. Cytokine 60: 369-376. doi:10.1016/j.cyto.2012.07.025. PubMed: 22898392.
25. Raqib R, Ahmed S, Sultana R, Wagatsuma Y, Mondal D et al. (2009) Effects of in utero arsenic exposure on child immunity and morbidity in rural Bangladesh. Toxicol Lett 185: 197-202. doi:10.1016/j.toxlet.2009.01.001. PubMed: 19167470.
26. Ahmed S, Ahsan KB, Kippler M, Mily A, Wagatsuma Y et al. (2012) In utero arsenic exposure is associated with impaired thymic function in newborns possibly via oxidative stress and apoptosis. Toxicol Sci 129: 305-314. doi:10.1093/toxsci/kfs202. PubMed: 22713597.
27. Zhang M, Xuan S, Bouxsein ML, von Stechow D, Akeno N et al. (2002) Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 277: 44005-44012. doi:10.1074/jbc.M208265200. PubMed: 12215457. (Pubitemid 36157826)
28. Courtland H-W, Elis S, Wu Y, Sun H, Rosen CJ et al. (2011) Serum IGF-1 Affects Skeletal Acquisition in a Temporal and Compartment-Specific Manner. PLOS ONE 6(3).
29. Tirapegui J, Baldi M, Ribeiro SL (1996) Effect of protein deficiency on plasma insulin-like growth factor-1 (IGF-1) level and protein and proteoglycan synthesis rates in skeletal muscle and bone. Nutrition Research 16: 869-879. doi:10.1016/0271-5317(96)00080-2.
30. Doyle JJ (1979) Toxic and essential elements in bone - a review. J Anim Sci 49: 482-497. PubMed: 389915.
31. Odstrcil AA, Ricci D, Mandalunis PM (2007) Toxic Effect of Arsenic in Bone Tissue of Experimental Growing Animals. The Preliminary Program for Sociedad Argentina de Investigación Odontológica, Argentine Society of Dental Research. Argentina.
32. Arena JMD (1986) Poisoning. In: CC Thomas. 5th ed. Springfield.
33. Ellenhorn MJ, Barceloux DG (1988) Arsenic In Medical toxicology. Diagnosis and treatment of human poisoning. New York: Elsevier.
34. Rahman M, Vahter M, Wahed MA, Sohel N, Yunus M et al. (2006) Prevalence of arsenic exposure and skin lesions. A population based survey in Matlab, Bangladesh. J Epidemiol Community Health 60: 242-248. doi:10.1136/jech.2005. 040212. PubMed: 16476755. (Pubitemid 43288631)
35. Vahter ME, Li L, Nermell B, Rahman A, El Arifeen S et al. (2006) Arsenic exposure in pregnancy: a population-based study in Matlab, Bangladesh. J Health Popul Nutr 24: 236-245. PubMed: 17195565. (Pubitemid 46151829)
36. Ahmed S, Mahabbat-e Khoda S, Rekha RS, Gardner RM, Ameer SS et al. (2011) Arsenic-associated oxidative stress, inflammation, and immune disruption in human placenta and cord blood. Environ Health Perspect 119: 258-264. doi:10.1289/ehp.1102086. PubMed: 20940111.
37. Persson LA, Arifeen S, Ekström EC, Rasmussen KM, Frongillo EA et al. (2012) Effects of prenatal micronutrient and early food supplementation on maternal hemoglobin, birth weight, and infant mortality among children in Bangladesh: the MINIMat randomized trial. JAMA 307: 2050-2059. doi:10.1001/jama.2012.4061. PubMed: 22665104.
38. de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C et al. (2007) Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ 85: 660-667. doi:10.2471/BLT.07.043497. PubMed: 18026621.
39. Gwatkin DR, Ergo A (2011) Universal health coverage: friend or foe of health equity? Lancet 377: 2160-2161. doi:10.1016/S0140-6736(10)62058-2. PubMed: 21084113.
40. Concha G, Vogler G, Lezcano D, Nermell B, Vahter M (1998) Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci 44: 185-190. doi:10.1093/toxsci/44.2.185. PubMed: 9742656. (Pubitemid 28415227)
41. Fängström B, Hamadani J, Nermell B, Grandér M, Palm B et al. (2009) Impaired arsenic metabolism in children during weaning. Toxicol Appl Pharmacol 239: 208-214. doi:10.1016/j.taap.2008.12.019. PubMed: 19167415.
42. Gardner R, Hamadani J, Grandér M, Tofail F, Nermell B et al. (2011) Persistent exposure to arsenic via drinking water in rural Bangladesh despite major mitigation efforts. Am J Public Health 101 Suppl 1: S333-S338. doi:10.2105/AJPH.2010.300025. PubMed: 21778503.
43. Nermell B, Lindberg AL, Rahman M, Berglund M, Persson LA et al. (2008) Urinary arsenic concentration adjustment factors and malnutrition. Environ Res 106: 212-218. doi:10.1016/j.envres.2007.08.005. PubMed: 17900556. (Pubitemid 351175629)
44. Walker BE, Payne RB (1979) Adjusted calcium conflict resolved? Differing effects on plasma total calcium of changes in plasma albumin after venous stasis or myocardial infarction. J Clin Pathol 32: 488-491. doi:10.1136/jcp.32.5.488. PubMed: 469006. (Pubitemid 9207995)